Fiscal Year Ending March 2026 Financial Summary [Japanese GAAP] (Consolidated)

Overview of Business Performance

Consolidated net sales for the fiscal year ending March 2026 reached a record high of 1,309.2 billion yen (0.9% YoY increase). Operating income was 106.4 billion yen (1.4% YoY decrease), reflecting reduced profits due to a slowdown in the EV market growth and a decline in demand for infectious disease test kits overseas. On the other hand, ordinary income reached a record high of 117.2 billion yen (5.6% YoY increase), supported by foreign exchange gains. Net income attributable to owners of parent was 75.1 billion yen (8.2% YoY decrease) due to impairment losses. By segment, the Housing Company posted higher sales and significant profit growth; the Environment & Life Infrastructure Company achieved record-high profits for the fourth consecutive period; the High-Performance Plastics Company increased sales but saw a profit decline; while the Medical Business experienced decreases in both sales and profits.

Outlook and Dividend Policy

For the fiscal year ending March 2027, net sales are projected at 1,408.4 billion yen (7.6% YoY increase), operating income at 115.0 billion yen (8.0% YoY increase), and net income attributable to owners of parent at 76.0 billion yen (1.1% YoY increase), with plans for increased sales and profits across all segments. The annual dividend is planned at 81 yen (1 yen increase), continuing the 16th consecutive year of dividend increases. To mitigate raw material procurement risks, the company intends to diversify sourcing and implement price pass-through. The medium-term management plan focuses on sustainable growth centered on expanding high value-added products and ESG management.